88R3072 BEE-D
 
  By: Hinojosa H.B. No. 1050
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the authority of pharmacists to dispense
  self-administered hormonal contraceptives.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Subchapter C, Chapter 157, Occupations Code, is
  amended by adding Section 157.102 to read as follows:
         Sec. 157.102.  AUTHORIZATION TO DISPENSE SELF-ADMINISTERED
  HORMONAL CONTRACEPTIVE UNDER WRITTEN PROTOCOL. (a) In this
  section:
               (1)  "Pharmacist" has the meaning assigned by Section
  551.003.
               (2)  "Written protocol" means a physician's written
  order, standing medical order, standing delegation order, or other
  order or protocol as defined by board rule.
         (b)  This section does not apply to:
               (1)  the issuing of a valid patient-specific
  prescription for a hormonal contraceptive by a physician; or
               (2)  the dispensing of a hormonal contraceptive by a
  pharmacist under a prescription described by Subdivision (1).
         (c)  A physician may issue a written protocol to authorize
  the dispensing of a self-administered hormonal contraceptive that
  is approved by the United States Food and Drug Administration to
  prevent pregnancy, including an oral hormonal contraceptive, a
  hormonal contraceptive vaginal ring, or a hormonal contraceptive
  patch.
         (d)  Notwithstanding any other law, in accordance with rules
  adopted under Subsection (e), a pharmacist may dispense a
  self-administered hormonal contraceptive to a patient 18 years of
  age or older under a written protocol and without any other
  patient-specific prescription drug order.
         (e)  In consultation with a national professional
  organization specializing in obstetrics and gynecology, the board
  shall jointly adopt rules with the Texas State Board of Pharmacy to
  establish standard procedures for a pharmacist to dispense a
  self-administered hormonal contraceptive under this section.
  Rules adopted under this subsection must require:
               (1)  a patient to complete and provide to a pharmacist a
  nationally recognized self-screening risk assessment before the
  pharmacist may dispense a self-administered hormonal contraceptive
  to the patient; and
               (2)  a pharmacist to provide the patient with
  information about the contraceptive dispensed to the patient.
         (f)  A physician acting reasonably and in good faith in
  issuing a written protocol for dispensing, or a pharmacist acting
  reasonably and in good faith in dispensing, a self-administered
  hormonal contraceptive under this section is not liable for civil
  damages resulting from an act or omission in the dispensing of the
  contraceptive.
         (g)  A law governing coverage by a health benefit plan of a
  contraceptive drug, device, product, or service applies to a
  self-administered hormonal contraceptive dispensed under this
  section to the same extent that the law applies to a
  self-administered hormonal contraceptive dispensed under a
  patient-specific prescription issued by a physician.
         SECTION 2.  Section 551.003(33), Occupations Code, is
  amended to read as follows:
               (33)  "Practice of pharmacy" means:
                     (A)  providing an act or service necessary to
  provide pharmaceutical care;
                     (B)  interpreting or evaluating a prescription
  drug order or medication order;
                     (C)  participating in drug or device selection as
  authorized by law, and participating in drug administration, drug
  regimen review, or drug or drug-related research;
                     (D)  providing patient counseling;
                     (E)  being responsible for:
                           (i)  dispensing a prescription drug order or
  distributing a medication order;
                           (ii)  compounding or labeling a drug or
  device, other than labeling by a manufacturer, repackager, or
  distributor of a nonprescription drug or commercially packaged
  prescription drug or device;
                           (iii)  properly and safely storing a drug or
  device; or
                           (iv)  maintaining proper records for a drug
  or device;
                     (F)  performing for a patient a specific act of
  drug therapy management delegated to a pharmacist by a written
  protocol from a physician licensed in this state in compliance with
  Subtitle B; [or]
                     (G)  administering an immunization or vaccination
  under a physician's written protocol; or
                     (H)  dispensing a self-administered hormonal
  contraceptive to a patient under a physician's written protocol
  under Section 157.102.
         SECTION 3.  Section 483.001(11), Health and Safety Code, is
  amended to read as follows:
               (11)  "Practice of pharmacy" has the meaning assigned
  by Section 551.003, Occupations Code [means:
                     [(A)  provision of those acts or services
  necessary to provide pharmaceutical care;
                     [(B)  interpretation and evaluation of
  prescription drug orders or medication orders;
                     [(C)  participation in drug and device selection
  as authorized by law, drug administration, drug regimen review, or
  drug or drug-related research;
                     [(D)  provision of patient counseling;
                     [(E)  responsibility for:
                           [(i)  dispensing of prescription drug orders
  or distribution of medication orders in the patient's best
  interest;
                           [(ii)  compounding and labeling of drugs and
  devices, except labeling by a manufacturer, repackager, or
  distributor of nonprescription drugs and commercially packaged
  prescription drugs and devices;
                           [(iii)  proper and safe storage of drugs and
  devices; or
                           [(iv)  maintenance of proper records for
  drugs and devices. In this subdivision, "device" has the meaning
  assigned by Subtitle J, Title 3, Occupations Code; or
                     [(F)  performance of a specific act of drug
  therapy management for a patient delegated to a pharmacist by a
  written protocol from a physician licensed by the state under
  Subtitle B, Title 3, Occupations Code].
         SECTION 4.  As soon as practicable after the effective date
  of this Act, the Texas State Board of Pharmacy and the Texas Medical
  Board shall adopt the rules required under Section 157.102,
  Occupations Code, as added by this Act.
         SECTION 5.  This Act takes effect September 1, 2023.